Introduction
Caffeine is a psychoactive substance present in several beverages and foods widely consumed in large amounts by children and adolescents with potential behavioral effects, like disruption of sleep and improved performance in tasks requiring close attention (Pollak and Bright, 2003; Bernstein et al., 2002) . Caffeine is a nonselective competitive adenosine A 1 and A 2A receptor antagonist with similar affinity (Fisone et al., 2004) . Its action on adenosine receptors seems necessary to enhance motor activity in experimental animals (Karcz-Kubicha et al., 2003) ; however, this effect has been described as the consequence of its blocks on adenosine A 2A receptors, rather than on A 1 receptors (El Yacoubi et al., 2000) .
Adenosine A 1 and A 2 receptors are widely dispersed in the brain at different intensities, which in turn contribute to the regulation of other neurotransmitters. Behavioral-and neurochemical evidences point to an antagonistic interaction relationship between adenosine A 2A -dopamine D 2 receptors (Ferre et al., 2004) and probably adenosine A 1 -dopamine D 1 receptors (Franco et al., 2007) . Adenosine A 2A and dopamine D 1 receptors couple to members of the G-proteins family that are positively related to intracellular cAMP production, as consequence of the activation of signaling via the PKA pathway (Stoof and Kebabian, 1981; Fredholm, 1977) and results in increased phosphorylation of dopamine-and cAMP-regulated phosphoproteins of 32 kDa (DARPP-32) (Walaas et al., 1983) . DARPP-32 is an important modulator of the cAMP/PKA pathway, highly expressed in Chronic ingestion of caffeine causes dependence and sleep disturbance in children and adolescents. In rodents, the administration of caffeine may produce behavioral cross-sensitization to some psychostimulants, such as dopaminergic psychoactive drugs. Methylphenidate (MPH; Ritalin 1 ) is a psychostimulant used in pediatric-and adult human populations to manage the symptoms associated with attention-deficit hyperactivity disorder (ADHD). Previous studies have suggested that dopamineand cAMP-regulated phosphoproteins of 32 kDa (DARPP-32) participate in the manifestation of behavioral activity following ingestion of caffeine or MPH. The aim of the present study was to evaluate whether long-term administration of low doses of caffeine in rodents during their adolescence induces cross-sensitization to MPH challenge in their adulthood and investigate the involvement of DARPP-32 in this model. Young rats (P25) consumed water or caffeine (0.3 g/L; mean consumption was 7.5 mg/day/ kg) for 28 days. The caffeine consumption was then suspended for 14 days (washout period) when the animals received saline solution or MPH (1, 2, or 10 mg/kg) (P67) intraperitoneally. The locomotor activity of these rats was assessed using the open-field test, following which the immunocontent of DARPP-32 was evaluated in samples of their prefrontal cortex, striatum, or hippocampus. Rats chronically exposed to caffeine in their adolescent period and to inactive doses of MPH (1 mg/kg) in adulthood showed augmented locomotor activity. The behavioral effect observed was accompanied by increased levels of DARPP-32 in the striatum and prefrontal cortex compared to control groups (saline or caffeine). However, no alteration caused by these treatments was noted in the hippocampus. In conclusion, chronic caffeine exposure induces likely long-term cross-sensitization to MPH in a DARPP-32-dependent pathway.
striatonigral neurons where the cascade pathway leads to increase in motor activity, and in striatopallidal neurons, the cascade is associated with motor depression (Borgkvist and Fisone, 2007) . Therefore, DARPP-32 is a potential molecular target for integrating the effects of adenosine-and dopamine receptors in locomotion (Lin et al., 2002) . The stimulant action of caffeine administered chronically (Lindskog et al., 2002) and cocaine administered either acutely (Svenningsson et al., 2000) or chronically (Bibb et al., 2001 ) is related to a persistent increase in DARPP-32 phosphorylation. In rodents, chronic caffeine induces behavioral cross-sensitization to dopaminergic- (Horger et al., 1991; Bastia et al., 2005; Simola et al., 2006a) and glutamatergic systems (Dall'Igna et al., 2003; da Silva et al., 2005) . The cross-sensitization phenomenon is described as a progressive behavioral augmentation that occurs when the pretreatment with one stimulant leads to greater sensitivity to another (Aizenstein et al., 1990) . Studies have demonstrated that adolescent rats pretreated with methylphenidate (MPH) develop subsequent cross-sensitization to amphetamine (Valvassori et al., 2007) or to cocaine in adulthood (Torres-Reveron and Dow-Edwards, 2005) . A significant proportion of the sensitization occurs via activation of the striatal D 1 receptors (Svenningsson et al., 2000) , mediating the rewarding properties of the drugs of abuse. In addition, an adaptative change in the neuronal circuits leads to abnormal DARPP-32 regulation participating in the induction-and expression of behavioral sensitization (Scheggi et al., 2007) . In spite of these observations, little is known about long-lasting effect of caffeineinduced cross-sensitization to MPH in adulthood when a lower dose of caffeine is ingested during adolescence. In this study, we evaluate whether long-term caffeine administration in adolescent rats induces cross-sensitization after MPH challenge in adulthood with the involvement of DARPP-32. Our results demonstrated that rats administered caffeine during adolescence express behavioral crosssensitization to MPH in adulthood, with changes in DARPP-32 content mainly in the striatum.
Experimental procedures

Animals
Male Wistar rats weighing 75-85 g (age 25 days) were used to begin the experiment. The animals were housed five to a cage (30 cm Â 40 cm Â 15 cm) with free access to food and water (or caffeine, where mentioned), and maintained on a 12-h light/dark cycle (lights on at 07:00 h). All experimental procedures performed were in accordance with the recommendations of the National Institute of Health Guide for the Care and Use of Laboratory Animals and the Brazilian Society for Neuroscience and Behavior (SBNeC) for animal care. The local ethics committee (Universidade do Extremo Sul Catarinense) approved the study (prot. 532/2007).
Pharmacological procedures
In the chronic treatment, caffeine anhydrate base solution (0.3 mg/L) was administered by allowing animals (age 25 days) free access to the solution in tap water bottles for 28 days (up to age 53 days, adolescence period) as their only drinking fluid. Control animals received ordinary tap water. Caffeine solutions were exchanged every third day for a fresh batch and the daily intake was measured in all groups. After chronic treatment, rats were randomly submitted to a 14-day washout period when every animal received ordinary water. On the 15th day (age 67 days, adulthood) they received acute challenge and were divided into eight groups as follows: (i) CRL group: administered chronic water and acute administration with saline solution (NaCl 0.9%, w/v); (ii) MPH1, (iii) MPH2 or (iv) MPH10 groups: administered chronic water and acute treatment with MPH 1, 2, or 10 mg/kg injected intraperitoneally, respectively; (v) CRL CAF group: administered chronic caffeine and acute administration with saline solution; (vi) CAF MPH1, (vii) CAF MPH2; or (viii) CAF MPH 10 groups: administered chronic caffeine and acute treatment with MPH (Ritalin 1 ) 1, 2, or 10 mg/kg, respectively. Twelve up to 15 animals were used per group, in a total of 101 animal for the experimental design. The dosages of MPH were selected according to a previous study that had shown sensitization of rats in adulthood to challenge with AMPH after chronic treatment with MPH in their teenage (Valvassori et al., 2007) .
Locomotor activity
The locomotor activity of the rats was assessed 2 h after acute injection of saline or MPH using the open-field apparatus (Vianna et al., 2001 ). At least 16 animals per day were submitted to tasks from 9 a.m. to 12 a.m. and a minimum of one animal of each group was evaluated. This study was conducted in an open field 40 cm Â 60 cm surrounded by 50-cm-high walls. The floor of the apparatus was of varnished wood and divided into nine equal rectangles by black lines. The animals were gently placed on the left rear rectangle and were allowed to explore the area. Crossings of the black lines and rearings by the rats were counted for a period of 5 min by expert blind observers.
Preparation of tissue sample
Immediately after behavioral assessment, the animals were decapitated and the cerebral prefrontal cortex, hippocampus, and striatum were dissected and rapidly solubilized with SDS-stopping solution (4% SDS, 2 mM EDTA, 8% b-mercaptoethanol, and 50 mM Tris, pH 6.8). Aliquots of the proteins were quantified (Bradford, 1976) and extracts stored at À80 8C until the preparation of samples for immunoblot analysis.
Immunoblot analysis
Equal amounts of protein (50 mg) were loaded into bis-Tris NuPAGE 4-12% gels (Invitrogen) and submitted to electrophoresis as recommended by the manufacturer, followed by their transfer to nitrocellulose membranes (Hybond ECL, Amersham Pharmacia Biotech). Protein loading and efficiency of blot transfer were monitored by staining with Ponceau S (0.5% ponceau/1% acetic acid) (Sigma Chemical Co., USA) (Towbin et al., 1979) . The membranes were blocked for 45 min with TBS-T (tris-buffered saline and Tween 20 0.1%, pH 7.4) plus non-fat milk 5%. Membrane blots were incubated with polyclonal anti-DARPP-32 (1:500 -H-62, Santa Cruz Biotechnology) and monoclonal anti-actin antibody (1:7000 -MAB1501R -Chemicon) diluted in TBS-T and stored overnight at 4 8C. After washing, the membranes were incubated for duration of one hour with goat antirabbit IgG (1:15,000) or goat anti-mouse IgG (1:7000) horseradish peroxidase (HRP)-conjugated secondary antibodies, respectively, which were purchased from Molecular Probes). Immunocomplexes were visualized using the enhancing chemiluminescence detection system (ECL Plus, Amersham Biosciences) as Fig. 1 . Effect on locomotion of long-term exposure to caffeine in adolescent rats MPH challenged in adulthood. Cumulative values of crossings (A) and rearings (B) in animals exposed to bottles of water (open symbols) or to bottles of caffeine 0.3 g/L (filled symbols), and challenged with acute MPH (1, 2, or 10 mg/kg) injections in adulthood measured as described in Section 2. Panels show data expressed as media AE S.E.M. of 11-15 animals.
a P < 0.05 compared to control water group, two-way ANOVA and post hoc Tukey HSD.
described by the manufacturer and visualized on ImageQuant. Densitometric analysis was performed using Scion Image Software version Beta 4.0.2 (Scion Corporation, Scion Corporation, Frederick, MD).
Statistical analysis
Results were analyzed by STATISTICA version 7.0 software (StatSoft, Inc., USA). All data are presented as mean values AE S.E.M. (standard error of the mean), and each value reflects the mean of 11-15 animals per group for behavioral parameters or the mean of 4-5 animals per group for immunoblot analysis. In all cases, statistical analyses were performed employing two-way analysis of variance (ANOVA) with chronic-and acute treatments as the main factors, followed by the Tukey HSD test for behavioral analysis and the Duncan test for immunoblot analysis. The level of significant difference was accepted at P < 0.05.
Results
Caffeine consumption of the rats was estimated from the loss of water from the drinking bottles. The daily liquid intake of all groups of rats (control and caffeine-treated with 0.3 g/L) did not differ from one another (data not shown) and the mean caffeine dose was 7.5 mg/kg per day.
In the open-field tasks (Fig. 1) , we observed an increase on the horizontal-[F (3,91) = 1.108, P < 0.05] ( Fig. 1A ; crossing) and the vertical locomotor behavior [F (3,91) = 2.048, P < 0.01] ( Fig. 1B ; rearing) in rats acutely treated with MPH 2 mg/kg challenge (MPH2 group), independent of their pre-treatment. Nevertheless, MPH 1 mg/kg challenge did not induce any modification per se, but did induce a hyperlocomotion in those rats pre-treated with caffeine during adolescence (CAF MPH1 group) [crossing: F (3,91) = 1.108, P < 0.01; rearing: F (3,91) = 2.048, P < 0.001]. Interestingly, neither chronic pre-exposure of caffeine (CRL CAF group) nor acute low dose of MPH alone (MPH1 group) altered the locomotor behavior of the animals.
The measurement of content of DARPP-32 protein normalized by actin content showed its different modulations to caffeine and/ or MPH in the cerebral area analyzed (Fig. 2) . Early treatment with MPH acute challenge [F (3,24) = 5.747, P < 0.001] as low dose of caffeine [F (3,24) = 5.747, P < 0.0001] reduced the DARPP-32 expression in the prefrontal cortex ( Fig. 2A) . The pre-treatment with caffeine in adolescence potentiated the effect induced by MPH 2 mg/kg (CAF MPH 2 group) [F (3,24) = 5.747, P < 0.05]. Conversely, treatment with all doses of MPH acute challenges or chronic treatment with caffeine induced increases in the contents of DARPP-32 in the striatum [F (3,24) = 7.466, P < 0.0001] (Fig. 2B) . In this cerebral area, pre-treatment with caffeine potentiated the increase in the content of protein induced by MPH 1 mg/Kg [CAF MPH1 group: F (3,24) = 7.466, P < 0.01]. Interestingly, in areas of the prefrontal cortex and striatum, caffeine-induced changes in the content of DARPP-32 showed an important long-lasting effect, which was altered by all doses of MPH only in the striatum of rats [CAF MPH1 group: F (3,24) = 7.466, vs. CAF group = P < 0.001, vs. MPH1 group = P < 0.01; CAF MPH2 group and CAF MPH10 group: F (3,24) = 7.466, vs. CAF group = P < 0.01]. The evaluation of DARPP-32 content in the hippocampus did not show any significant changes following all treatments (Fig. 2C) .
Discussion
The present findings show for the first time the long-lasting effects of the interaction of caffeine and MPH at adulthood, following the chronic free exposure of adolescent rats to low doses of caffeine. The sensitization of dopaminergic drugs, such as MPH, amphetamine, and cocaine to caffeine is known; however, the protocols of treatments were carried out at the same phase or age of animals (Schenk et al., 1990; Jain and Holtzman, 2005; Simola et al., 2006b ). The present model was designed to investigate whether chronic exposure to caffeine in the adolescent period induces behavioral cross-sensitization to MPH in adulthood after the washout period, and besides investigated the possible involvement of the DARPP-32 protein in this phenomenon.
Caffeine exerts ontogenetic psychostimulant effects in humans (Oliveto et al., 1992; Bernstein et al., 2002; Pollak and Bright, 2003) , and in rats its effects have been demonstrated to be influenced by dopamine transmission. Because caffeine induces the release of dopamine in the striatal compartments (Solinas et al., 2002) and prefrontal cortex (Acquas et al., 2002) , its effect on motor activation is reduced by dopaminergic receptor antagonists (Garrett and Holtzman, 1994) , whereas sensitization of dopamine receptors enhances the caffeine effect (Fenu and Morelli, 1998) . Several lines of evidence have established that the psychostimulant effects of caffeine are mediated by an antagonism at the adenosine A 1 and A 2 receptors levels (Fisone et al., 2004) , whereas the adenosine A 2A receptors play a fundamental role in caffeinemediated motor behavior (El Yacoubi et al., 2000) . The dopamineand adenosine cross-talk via caffeine have been supported by identification of heteromeric dimerization of the adenosine A 2A and dopamine D 2 receptors (Ferre et al., 2004; Tsai, 2005) , and probably adenosine A 1 receptors regulate the D 1 receptors (Yabuuchi et al., 2006) . The striatal complex is involved in the behavioral responses to motivational stimuli due its dorsolateral area innervation from the substantia nigra pars compact (SNpc) involved in motor functions, and its ventral-(nucleus accumbens) and dorso medial areas innervation from the ventral tegmental area involved in motivational-and reward behaviors. Dopamine via D 1 receptors controls mainly the motor function via increase of the cAMP signaling pathway whereas via D 2 receptors are involved in motivation via a reduction of its pathway (Borgkvist and Fisone, 2007) . Adenosine A 1 and A 2A also are expressed in the striatal area; however, the A 1 is present in lower density (Rivkees et al., 1995) and the A 2A is highly expressed postsynaptically (Fink et al., 1992) . The observed potentiation of locomotion of rats induced by exposure to caffeine during adolescence and MPH challenge at adulthood at low dose could represent the interaction referred above. In addition, probably this behavioral sensitization had the participation of DARPP-32 in the striatum, since studies have demonstrated its activation in this phenomenon (Scheggi et al., 2007) that present data corroborated when the caffeine treatment during adolescence and acute administration of MPH challenge in adulthood significantly changed the content of protein. DARPP-32 protein was initially found to be a major target for dopamineactivated adenylyl cyclase and protein kinase A (PKA) in the striatum (Walaas et al., 1983) . A prominent aspect of the distribution of DARPP-32 in the brain is its high enrichment in dopaminergic neurons, including the striatal medium spiny projection neurons (Anderson and Reiner, 1991) and in lower density in the brain regions receiving dopaminergic projections, including the prefrontal cortex (Ouimet et al., 1984) . The involvement of DARPP-32 in the action of caffeine (Lindskog et al., 2002) and amphetamines demonstrates the importance of the cAMP/PKA pathway in the induction of behavioral stimulation (Svenningsson et al., 2000) . Since dopamine exerts a strong influence on inhibition in the prefrontal cortex and the low levels of dopamine in this area preferentially act on D 1 receptors (Trantham-Davidson et al., 2004) , probably the reduced content of DARPP-32 observed here represents the effect of long-term treatment with caffeine in teenage rather than an effect induced by the dopamine released. The hippocampus being highly enriched with adenosine A 1 receptors (Rivkees et al., 1995) receives dopaminergic projection, which releases the dopamine that could bind on the D 1 receptors (Trantham-Davidson et al., 2004) . In this area, the immunohistochemistry identification of DARPP-32 is significantly lower than other areas observed here (Ouimet et al., 1984) . Since our results demonstrated no change in DARPP-32 content in the hippocampus following treatment with caffeine or MPH, we suggest that the long-lasting effect of caffeine on the DARPP-32 content in the striatum and prefrontal cortex was due its action on the adenosine A 2A receptors.
The several studies that investigated the effect of caffeine in behavior point to molecular action. It is essential to associate caffeine with the other psychostimulant, since both substances can modulate acutely or chronically the neural cells in the brain. Caffeine is the most widely consumed psychoactive substance on earth and is used at least weekly by nearly all adults, thus investigations on its interaction with neurotransmission system, such as the dopaminergic system, have been ongoing since several years. However, little is known about its chronic use in lower doses in children treated for psychiatric disorders. In the present work, we investigated the sensitization expression following chronic caffeine administration in adolescence to MPH in adulthood, evaluating the behavior-and biochemistry alterations in rats. The results showed important cross-sensitization effects induced by caffeine to MPH with the participation of DARPP-32 protein in the dopaminergic brain areas involved in the regulation of motor-and action behaviors.
